Track the 디알텍 stock price and the full management transaction log of the company, a listed issuer based in South Korea. Shares are listed on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 디알텍 has logged 41 reports. Market capitalisation: €96.6bn. The latest transaction was filed on 23 June 2026 (Other). Among the most active insiders: 윤정기. Every trade is openly available.
41
Insider Decl.
0
Thresholds
€5,735
15 ops.
Buy Volume
·
8 ops.
Sell Volume
22Σ signal
Buys €5,735· Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 24,509 of 26,220 companies
18.0
score / 100
Value
12
Quality
24
FCF yld-17%
Earn yld-15%
EV/EBITDA·
ROE-27%
Gross mgn36%
Net mgn-21%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
디알텍 is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX market. It specializes in developing innovative solutions for the medical field.